Agoracom Blog Home

Archive for the ‘Featured’ Category

« Older Entries
Newer Entries »

Else Nutrition $BABY.ca Announces the U.S. Launch of Trial Samples of its Plant-based Nutrition Product for Toddlers $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:15 AM on Monday, June 22nd, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Plant-based Complete Nutrition for Toddlers Trial Pouches to be widely available on ElseNutrition.com e-store
  • (1.27 oz) will be available at no charge, with customers covering only the shipping costs
  • The sampling campaign will be promoted via Else social media channels and will precede the launch of the full-size version of the product, which will be available for pre-orders on our e-store this July

VANCOUVER, BC, June 22, 2020 - ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company“), is pleased to announce the U.S. launch of trial-sized pouches of Else Plant-based Complete Nutrition for Toddlers.

Following successful production, the trial samples of Else’s proprietary product will now be widely available for order via the elsenutrition.com e-store.

“We are thrilled to hit this key milestone and to be sharing our product with the world. It is indeed a major inflection point as we continue down the path toward commercialization of our first product. We are excited to get the samples in the hands of eager parents looking for clean label, plant-based nutrition alternatives for their children,” said Ms. Hamutal Yitzhak, CEO & Co-Founder.

Else Plant-Based Complete Nutrition for Toddlers trial pouches (1.27 oz) will be available at no charge, with customers covering only the shipping costs. The sampling campaign will be promoted via Else social media channels and will precede the launch of the full-size version of the product, which will be available for pre-orders on our e-store this July.

Samples can be ordered at: www.elsenutrition.com.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition), University Hospital Brussels, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center, Plum Organics.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Tags: , , , , , ,
Posted in Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca Announces the U.S. Launch of Trial Samples of its Plant-based Nutrition Product for Toddlers $KMB $BMY $ABT $WYE

Else Nutrition $BABY.ca – A Novel Product for Child Nutrition MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 4:18 PM on Friday, June 19th, 2020

Else Nutrition Holdings Inc. (TSX-V: BABY) The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q3 2020 with International agreements to follow. Learn More

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

A Novel Product for Child Nutrition

  • ELSE stands out as a unique supplemental beverage for 3-12 year-olds
  • It has the essential vitamins and nutrients that many children lack in their usual diets
  • Unlike competitor products, ELSE contains no milk or soy proteins, also making it ideal for kids with such allergies

by Dr. Leah Alexander

Ensuring that a child has a balanced, healthy diet can be a challenge for parents.  Every family situation is different, but a variety of factors can prevent children from eating nutritious foods.  Some families live in communities where access to fresh food markets is limited.  Instead, fast food establishments and convenience stores are the only local food sources.  Other families live in areas of food shortages due to climate effects, civil unrest, or poverty.  In other cases, it is simply that a child has developed taste preferences for high fat, sweetened, and salty foods due to introduction during the toddler years.  Whatever the reason, a report by The United Nations Children’s Fund (UNICEF), “State of the World’s Children 2019,” shows some startling statistics (source):  

  • 1 in 3 children under the age of 5 are either undernourished or overweight, resulting in stunting of growth, muscle wasting, and obesity
  • 1 in 2 children suffers from “hidden hunger,” deficiencies in vitamins and essential nutrients
  • 1 in 5 children aged 5 to 19 are considered overweight (BMI >19)

The World Health Organization’s analysis provides similar results (source).  Children worldwide are not consuming the proper nutrients in their diets.

A healthy diet is important for optimal growth and cognitive development.  Calcium absorption for maximum bone density, increase in muscle mass, and brain maturation occurs throughout childhood.  If the appropriate nutrients are lacking, these important milestones are affected.  Iron, in particular, is important for brain function;  research has shown reduced academic achievement in the presence of iron deficiency (source).  Unfortunately, children are not consistently eating enough of the right kinds of foods.  According to the Centers for Disease Control and Prevention (CDC), calories from added sugars and fats contribute to 40% of the daily caloric intake for children aged 2 to 18 (source).  The primary sources of these calories come from soda, fruit drinks, desserts, pizza, and whole milk.  Based on this, it is clear that improvements need to be made regarding global child nutrition.

The WHO recommends a balanced diet of grains or tubers (i.e. potatoes, yams), legumes, vegetables, fruits, and proteins (source).  Vegetables and fruits provide essential vitamins, minerals, fiber, plant protein, and antioxidants.  These all lower the risk of obesity, heart disease, type II diabetes, and some forms of cancer.  A diet with adequate protein is important for both muscle and tissue building.  How much of each food group a child should eat varies by age, gender, and amount of physical activity (source).  When too much or too little are consumed, the risk of health-related illness increases.

A Pediatric Perspective 

In clinical practice, I have witnessed a variety of childhood eating habits.  In the best scenario, some children seem to naturally be “healthy eaters,” enjoying any food put on the plate.  Other kids prefer only fruits, therefore, missing the nutrients vegetables would provide.  Then, there are children who will only eat a few foods from each food group.  While some of these “selective eaters” have a diagnosed developmental disorder or autism, many do not.  Additionally, there seems to be a preference for what I call the “Kid Junk Food Trifecta”:  chicken nuggets, macaroni and cheese, and pizza.  The chicken nuggets are typically from a fast-food establishment, the macaroni is the “boxed” version, and, by pizza, it means only dough, sauce, and cheese.  Although there are many theories as to why children may refuse healthy foods, research has shown an association of food marketing with unhealthy food choices.  Advertisers promote products that are kid-friendly but often low in nutritional value (source).  When seen often enough, children find the advertised food to be more appealing, choosing it over healthier options.

Efforts to Improve the Current Trends in Child Nutrition 

In order to address the UNICEF concerns about stunted growth during the early childhood years, nutritional beverages have been developed by infant baby formula companies.  In theory, by offering a supplement with vitamins, proteins, fats, and carbohydrates, parents have another way to provide essential nutrients.  Creative marketing has convinced many parents that these products are nutritious and beneficial.  Examining the ingredients, however, there are some concerns.  The second or third ingredient is often sugar.  While this added sugar may give an appealing taste to the product, it can promote tooth decay and obesity.  It also increases the likelihood of developing type II diabetes later in life.  Although it may not have been the intention of the developers, the high sugar content of these beverages puts them in the category of a “sugary drink,” something the American Academy of Pediatrics discourages  (source).  The CDC agrees, stating that no more than 10% or 200 calories of one’s total daily calories should come from sugar (source).  The currently available nutritional beverages contain 12-18% sugar, much more than is recommended.  Fortunately, there is a much better option, ELSE.

Else Plant-Based Kids Nutritional Drink

ELSE stands out as a unique supplemental beverage for 3-12 year-olds.  It has the essential vitamins and nutrients that many children lack in their usual diets.  Unlike competitor products, ELSE contains no milk or soy proteins, also making it ideal for kids with such allergies.  Those who follow a vegan diet will find this aspect appealing as well (some versions of the competitor product contain tuna oil).  There are no artificial flavors in ELSE.  As an added bonus, ELSE contains the essential fatty acids docosahexaenoic acid (DHA) and arachidonic acid (ARA).  Although most important during the first 2 years of life, there is growing evidence of the benefits of DHA in older children and adults (source).

There are some special situations where ELSE may be beneficial.  For example, children with inflammatory bowel disease often eat less due to abdominal pain, and their bowel inflammation impairs nutrient absorption.  ELSE could be a source of nutrients that are difficult for these children to get.  Young cancer patients suffering from anorexia during chemotherapy treatments may benefit from this product as well.  In situations of food scarcity, such as during a natural disaster, ELSE could be a temporary, supplemental source of nutrition. 

The WHO has set goals for child nutrition with the hope of meeting them by 2025.  They seek to lower the rates of stunted growth under age 5, to reduce childhood wasting to less than 5%, and to stop the rise of childhood obesity (source).  A healthier nutritional supplement such as ELSE may be just the product needed to help achieve these goals.

Source: https://elsenutrition.com/blogs/news/else-a-novel-product-for-child-nutrition

Tags: , , , , ,
Posted in Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca – A Novel Product for Child Nutrition MAT $KMB $BMY $ABT $WYE

$KABN.ca North America to Present Company and Product Showcase

Posted by AGORACOM-JC at 8:45 AM on Thursday, June 18th, 2020
This image has an empty alt attribute; its file name is image-3.png
  • Live online overview and demonstration with Q & A – July 7th and 8th – 12 pm to 1 pm Eastern
  • With the evolving macroenvironment and the increasing amount of time spent online, the Company believes that digital identity will become more important as users look to work, play, educate, game and shop virtually and will need to protect, manage and control the use of their digital identity

Toronto, Ontario–(June 18, 2020) – KABN Systems NA Holdings Corp. (CSE: KABN) (the “Company” or “KABN” or “KABN North America“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization, is pleased to announce that the Company will be holding an online overview and demonstration of its product suite on July 7th and 8th at 12 pm Eastern. Participants will also have the opportunity to ask questions.

With the evolving macroenvironment and the increasing amount of time spent online, the Company believes that digital identity will become more important as users look to work, play, educate, game and shop virtually and will need to protect, manage and control the use of their digital identity.

KABN North America is currently in development to beta launch its suite of products later this month. These include:

KABN North America Product Suite

KABN North America has 4 primary products that enable users to verify, manage and monetize their digital identity:

  • KABN ID: a reusable, Always On, compliant, biometrically based, identity verification and validation platform that forms the engine of the KABN Network.
  • LIQUID AVATAR: a digital image-based “wallet and keyring” platform that allows users to create high quality digital icons representing their online personas in order to manage their digital identity.
  • KABN Card: an approved prepaid Visa card that includes a mobile banking wallet that supports both digital and traditional currencies.
  • KABN KASH: a robust loyalty and engagement platform with cashback and card-linked programs.

KABN believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity. The KABN North America platform provides, at no cost to consumers, the ability to create a digital identity with our Liquid Avatar platform (www.liquidavatar.com), verify their identity through KABN ID and create value for the use of their identity through KABN North America’s cashback, engagement and loyalty program, KABN KASH, as well as the KABN Visa card.

KABN North America generates revenue by providing our users with, at no cost, high value services and delivering permission-based offers that fit their aggregated public data profiles. KABN never rents, sells or provides data to outside parties without permission, and complies with jurisdictional privacy rules and regulations.

To Register for the KABN Showcase, please visit the following:

For July 7th at 12 pm to 1 pm Eastern:

https://aw14bfc0.aweb.page/p/d4e2ce95-8957-4fc7-be5c-3384a511398e

For July 8th at 12 pm to 1 pm Eastern:

https://aw14bfc0.aweb.page/p/b82604b4-cc9e-4e7a-86ba-ebcec20ab856

For more information on KABN North America and its suite of products, please visit:

www.kabnnaholdco.com or www.kabnsystemsna.com

About KABN – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.

KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs.

KABN Systems NA Holdings Corp. is publicly traded on the Canadian Securities Exchange under the symbol: KABN

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

Ben Kessler
Chief Executive Officer
647-725-7742 Ext. 700

[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Tags: , , , ,
Posted in Featured, KABN Systems NA Holdings Corp. | Comments Off on $KABN.ca North America to Present Company and Product Showcase

Datametrex $DM.ca Sold $1.5m Test Kits and Provides 90 Day Corporate Update on #COVID19 With Sales Outlook

Posted by AGORACOM-JC at 8:01 AM on Thursday, June 18th, 2020
  • Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies
  • Total gross sales of approximately $1.5 million CAD
  • Datametrex has little or no upfront costs associated with the sale of these test kits
  • Company’s project pipeline is significant on both the COVID-19 test kits and Personal Protective Equipment based on multiple projects in various stages of development across Canada, US, Africa, Asia, Australia and the EU

TORONTO, June 18, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to share a corporate update that since announcing on April 16, 2020, that it secured the rights to import and sell high-quality South Korean manufactured Nucleic Acid COVID-19 test kits.

Datametrex continues supporting companies through facilitating COVID-19 test kits, along with big data AI analytics tools that can help target future outbreaks, potentially source fake news that can be detrimental to the operations, or even visualize the audience that needs the fastest response in these critical times.

NEW REVENUE

The Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies, for total gross sales of approximately $1.5 million CAD. Datametrex has little or no upfront costs associated with the sale of these test kits.

HIGHLIGHTS

  • Since May 15th, Datametrex has generated gross sales of $500,000 with the sale of 10,000 test kits and one (1) PCR machine to a large Canadian mining company with operations in West Africa.
     
  • Since June 8th, Datametrex has sold $810,000 with initial orders comprising of 12,000 test kits and six (6) PCR machines to two Canadian companies.

  • On June 9th the Company arranged with lab partner Transpharm Canada Inc. (“TCI”) to conduct ongoing testing for a private Quebec metal mining company with an initial order of 2,000 test kits generating gross sale of approximately $250,000 for Datametrex.

“With the resurgence of a second wave of COVID-19 in multiple countries, and with a worldwide attempt to reduce lockdown measures to get citizens back to work, the demand for testing will only increase. These rapid antibody-based tests are a vital tool for jumpstarting the economy,” says Marshall Gunter, CEO of the Company. “Datametrex is pleased to facilitate the sale of these test kits globally providing worldwide, the opportunity to use top quality test kits to flatten the curve and get back to the “new normal” safely.”

Advisory Board and New Personnel

On May 4th, Todd Shapiro consented to join the Board of Directors of Datametrex. After being a top rated Radio Show host & a brilliant marketing Entrepreneur with over 20 years of experience, he has recently moved on from main stream media to concentrate his efforts on being the CEO of Red Light Holland. Todd currently sits on the Board of Directors for Red Light Holland, JamStacked and Mogul Productions.

On May 19th, Datametrex added President and Dean of the Toronto Institute of Pharmaceutical Technology (“TIPT”) and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., to the Company’s Medical Advisory Board.

On June 10th, the Company welcomed Edward Choi, to head up the sales team in Seoul, South Korea. Edward was a Vice President at LOTTE for leading Lotte’s cyber security division.

Datametrex Pipeline

The Company’s project pipeline is significant on both the COVID-19 test kits and Personal Protective Equipment (“PPE”) based on multiple projects in various stages of development across Canada, US, Africa, Asia, Australia and the EU. We are waiting for PO approvals with specified COVID-19 sales and or tender proposal process. The Company will recognize revenue upon sale and shipment of the test kits. The Company will also receive additional revenue streams as we secure new business and continue to provide Ai services, fullfill contracts and or supply agreements to goverments, corporate customers upon fulfillment.

About Transpharm Canada Inc.

Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies. Additional information on TIPT is available at www.tipt.com

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Sold $1.5m Test Kits and Provides 90 Day Corporate Update on #COVID19 With Sales Outlook

VIDEO: MedX $MDX.ca #Telemedicine Platform For Skin #Cancer Gets Record Order, Set To Generate Millions In 2020

Posted by AGORACOM-JC at 4:16 PM on Wednesday, June 17th, 2020
Home - MedX Health

MedX (MDX:TSXV) is the “overnight 5-year success story” that most retail investors have never heard about … but that is all about to change in 2020, a year that is set to dwarf the $860,000 in revenue MDX generated in 2019.  

What do they do?  In layman’s terms, they’ve combined their skin cancer scanning device with proprietary software to create a telemedicine platform focused on skin cancer.  In essence, you scan a troubling spot on your body and within 72 hours you can have both a prognosis and treatment completed – god forbid.  

Sounds like a cool idea but does it work?  Glad you asked.  The platform was proven through a proof-of-concept trial in Norway where 109 pharmacies captured 80,000 scans and found 860 cases of melanoma.  

2020 is shaping up to be both the Company’s best year ever and the beginning of something potentially great.  Why?  

1.  MDX signed an exclusive distribution deal that led to the Company receiving its biggest order in history – 500 units.  With much more expected to come due to minimum annual sales requirements.

2.  MDX just did the same thing in Mexico on Monday.  

Mike Druhan, Vice President of Corporate Development, believes more countries are set to follow.  We’d love to tell you more but trust us when we tell you that we’ve saved the best for the interview.  

Telemedicine is going to be a monster, disruptive industry this decade and MDX has the early upper hand in the world of skin cancer.  

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: , , , , , ,
Posted in Featured, MedX Health Corporation | Comments Off on VIDEO: MedX $MDX.ca #Telemedicine Platform For Skin #Cancer Gets Record Order, Set To Generate Millions In 2020

TransCanna $TCAN.ca Expands Distribution into the Los Angeles Market $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:53 AM on Wednesday, June 17th, 2020
tcan-square
  • Announce through its wholly-owned subsidiary Lyfted Farms Inc. an Inventory and Product Agreement with Cali Plug UHCC for its highly anticipated inaugural retail location
  • Cali Plug was founded in 2006 and is a significant influencer in the cannabis space, with approximately 200,000 Instagram followers (@caliplug)

Vancouver, British Columbia–(June 17, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce through its wholly-owned subsidiary Lyfted Farms Inc. (“Lyfted”) an Inventory and Product Agreement (the “Agreement”) with Cali Plug UHCC for its highly anticipated inaugural retail location. Cali Plug was founded in 2006 and is a significant influencer in the cannabis space, with approximately 200,000 Instagram followers (@caliplug).

July 2020 is the target date for the grand opening of this store. Through this Agreement, Lyfted Farms is expanding distribution into the greater Los Angeles area in collaboration with the brand new Cali Plug UHCC dispensaries www.calipluguhcc.com.

Cali Plug UHCC plans to feature the Lyfted Farms products in the new store and use their social media platforms to promote the Lyfted brand. Cali Plug has estimated foot traffic to exceed 1,000 customers daily for the downtown store. The first dispensary will be prominently located in downtown Los Angeles at 5925 South Alameda Street.

“Lyfted Farms is a powerhouse for premium indoor cultivation flower. Moving into the So-Cal market with Cali Plug flagship retail is going to be an incredible collaborative force,” states Cali Plug, Owner and Founder Michael Myers. “The flower is going to fly off the shelves. The So-Cal consumers demand the quality that Lyfted Farms can produce.”

Cannabis sales in California are expected to exceed U$5.1 billion for 2020, with more than half of that happening in the greater Los Angeles area. Southern California is the largest cannabis consumer market in the world.

“This Agreement helps us realize our broader strategy of aligning with authentic long-term California cannabis innovators while staying true to our end consumer,” said Bob Blink, Lyfted Farms Founder and TransCanna CEO. “We continue to build out the go-to-market strategy in anticipation of imminently receiving our Daly Building license.”

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , , , ,
Posted in Featured, TransCanna Holdings Inc. | Comments Off on TransCanna $TCAN.ca Expands Distribution into the Los Angeles Market $CGC $ACB $APH $CRON.ca $OGI.ca

VIDEO – ImagineAR $IP.ca Makes Augmented Reality History With Broward Education Foundation, Flo Rida and Dwyane Wade Delivering Diplomas To Graduates Via #AR $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 5:50 PM on Tuesday, June 16th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

If you don’t know what Augmented Reality (AR) is, this quote from Apple CEO Tim Cook is all the motivation you need to get up to speed:  

“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”  

    AR is essentially a technology that lays digital images and graphics over the real world.    

As the name implies, ImagineAR (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality Company that enables businesses to create their own mobile phone AR campaigns with no programming or technology experience.  More than just lip service, the Company recently announced a partnership with the Broward Education Foundation to create #2020gradsecret – an immersive augmented reality (AR) mobile experience for students graduating from Broward County Public School.  

Using the free ImagineAR app, grads are recording themselves in their homes accepting diplomas from Broward Schools Superintendent Robert Runcie, joining international music superstar Flo Rida for a congratulatory message or dancing with either one of them-and instantly sharing the videos on social media.  Adding in a congratulatory message is NBA superstar Dwyane Wayde.  

Flo Rida stated “This futuristic ImagineAR augmented reality technology is a trip” “I’m happy to help these graduates define a new way of celebrating and social interaction as they move on to the next chapter in their young lives.”  

How well is this Augmented Reality Diploma experience working out so far?  Pejay Ryan, director of marketing for Broward Education Foundation said “The feedback has been off the hook.  It is going to blow your mind.”

That quote is just the tip of the iceberg.  Watch what Ryan has to say about why they selected ImagineAR and how “the sky is the limit on other applications”.   

ImagineAR (IP:CSE) is the Augmented Reality company that allows small cap investors to participate in the growth of the space, which IP says is projected to grow ~ 2,000% in the next 4 years …. that is not a typo!

ImagineAR has already started commercializing their mobile Augmented Reality Platform with clients that include:

  • NBA Sacramento Kings
  • Mall Of America
  • AT&T Shape
  • Basketball Hall Of Fame
  • ….. more

As a result, ImagineAR is now well positioned to further commercialize and capitalize on massive demand for Augmented Reality.  

If our interview with CEO Alen Paul Silverrstieen and Pejay Ryan is any indication, it sounds like the Company’s growth into the education / graduation business is all but assured in 2020 and well beyond.  

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, Featured, Imagine AR | Comments Off on VIDEO – ImagineAR $IP.ca Makes Augmented Reality History With Broward Education Foundation, Flo Rida and Dwyane Wade Delivering Diplomas To Graduates Via #AR $VST.ca $YDX.ca $NTAR.ca

VIDEO – $KABN.ca Integrates It’s Digital Privacy Solution On Platform With 60 Million+ Gamers

Posted by AGORACOM-JC at 10:38 AM on Tuesday, June 16th, 2020
This image has an empty alt attribute; its file name is image-3.png

When the Facebook data privacy scandal broke out, the world woke up to just how badly our individual data was being traded, used and most importantly, the amount of profit being generated by major corporations at our expense.  

This led to the enactment of the biggest data privacy laws in history.  Specifically, General Data Protection Regulation (GDPR) out of Europe and the California Consumer Privacy Act (CCPA).  

Enter KABN.  The Company Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.  

KABN’s timing could not be more perfect and today’s press release confirms the industry’s enthusiasm for their digital privacy solution.  

“Liquid Avatar Integrates with Disrupted Logic Interactive to Reach 60 Million+ Gamers”  

Watch this interview with President David Lucatch and welcome to the next great disruptive industry of the decade!

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Featured, Fintech, KABN Systems NA Holdings Corp. | Comments Off on VIDEO – $KABN.ca Integrates It’s Digital Privacy Solution On Platform With 60 Million+ Gamers

$KABN.ca – Liquid Avatar Integrates with Disrupted Logic Interactive to Reach 60 Million+ Gamers

Posted by AGORACOM-JC at 8:46 AM on Tuesday, June 16th, 2020
This image has an empty alt attribute; its file name is image-3.png

> Entered an initial agreement to integrate its Liquid Avatar platform (www.liquidavatar.com) with Disrupted Logic Interactive’s (“DLI”) ctalyst® platform to enhance the experience of online and eSports gamers.

> DLI’s ctalyst® platform currently works with over 130 game producers and has an additional 150 developers awaiting invitation to join the network

> ctalyst® is a one-stop, self-contained, and full-service platform similar in concept to Google’s AdWords, AdSense, and Analytics, but designed just for video games and e-sports

> With the 130 game producers, the peak reach has been 60 to 70 million players and manages over 150 unique data points and analytics on opt-in participants.

Toronto, Ontario and Vancouver, British Columbia–(June 16, 2020) –  KABN Systems NA Holdings Corp. (CSE:KABN) (formerly Torino Power Solutions Inc.) (the “Company” or “KABN” or “KABN North America“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization, is pleased to announce that it has entered an initial agreement to integrate its Liquid Avatar platform (www.liquidavatar.com) with Disrupted Logic Interactive’s (“DLI”) ctalyst® platform to enhance the experience of online and eSports gamers.

Founded in 2012 in Vancouver, BC, by a team of seasoned video, gaming, advertising and technology leaders, DLI’s ctalyst® platform currently works with over 130 game producers and has an additional 150 developers awaiting invitation to join the network. ctalyst® is a one-stop, self-contained, and full-service platform similar in concept to Google’s AdWords, AdSense, and Analytics, but designed just for video games and e-sports. With the 130 game producers, the peak reach has been 60 to 70 million players and manages over 150 unique data points and analytics on opt-in participants. It is anticipated that when the additional 150 game developers are invited into the program, the reach could extend to over 500 million gamers worldwide.

KABN North America’s platform provides, at no cost to consumers, the ability to create a digital identity with the Liquid Avatar platform, verify their identity through KABN ID and create value for the use of their identity through KABN North America’s cashback, engagement and loyalty program KABN KASH, as well as the KABN Visa card.

KABN North America generates revenue by providing users with high value services and delivering permission-based offers that fit their aggregated public data profiles. KABN never rents, sells or provides data to outside parties without permission, and complies with jurisdictional privacy rules and regulations.

KABN North America is working with DLI and its game developers to promote Liquid Avatar to US and Canadian gamers through the online game registration and certain game incentives.

“The ability to increase player reach outside of the game and the ability to empower users to control the use of their digital identity is a fundamental reason why we’ve partnered with Liquid Avatar,” said Tom Raycove, CEO of DLI. “KABN’s ecosystem presents a tremendous opportunity for DLI and our game developers to create revenue while building increased value for players.”

Liquid Avatar – Delivering Reach, Value and Revenue

Game Developers – Liquid Avatar provides developers with the ability to extend their reach and revenue generation with players by having gamers activate Liquid Avatars. Any revenues generated by those gamers in the KABN Network will be shared by KABN, DLI and game developers.

Advertisers – For in-game advertisers, DLI manages over 150 unique data points and, together with Liquid Avatar, can assess if a gamer has more than 1 account, allowing unique advertising to be delivered not just based on individual game play of an individual person and not just the number of accounts, increasing both value for the advertiser and potentially increasing overall revenue in the ecosystem.

Gamers – By signing up in-game for a Liquid Avatar account, the user will have the ability to earn special rewards and value from the game developer. They will also have the ability to potentially create and manage in-game avatars with Liquid Avatar and extend their game personas to the real world. Working with DLI, the data points collected can support both the opportunities in Liquid Avatar and products like KABN KASH to create more personalized offers from merchants and increase the potential revenue generated by KABN North America.

DLI / catalyst® – The agreement with KABN North America provides opportunities for DLI to increase their ongoing reach with gamers, create value for the ecosystems and generate revenues beyond in-game advertising. Liquid Avatar and KABN will share revenues generated inside the KABN ecosystem for users generated from DLI’s referrals.

KABN North America – By working with DLI and other organizations that have large networks of non-verified users, Liquid Avatar can potentially create significant revenue and value for its partners and the KABN Network. This process both increases reach for Liquid Avatar and can potentially reduce customer acquisition costs significantly.

KABN North America Product Suite

KABN North America has 4 primary products that enable users to verify, manage and monetize their digital identity:

  • KABN ID: a reusable, Always On, compliant, biometrically based, identity verification and validation platform that forms the engine of the KABN Network.
  • LIQUID AVATAR: a digital image-based “wallet and keyring” platform that allows users to manage their digital identity.
  • KABN Card: an approved prepaid Visa card that includes a mobile banking wallet that supports both digital and traditional currencies.
  • KABN KASH: a robust loyalty and engagement platform with cashback and card-linked programs.

“This agreement with DLI creates an opportunity to reach a significantly large, low acquisition cost and highly scalable market to increase the reach of Liquid Avatar,” said Benjamin Kessler, CEO. “KABN’s suite of services will provide an ecosystem to empower these users to manage and control their digital identity and to benefit from unique, permission-based offers that will create revenues for KABN, DLI and game developers.”

DLI is currently exploring its own private funding program and KABN North America has expressed interest in participating as a lead order, subject to completion of a definitive agreement, review of the offering, and receipt of all necessary approvals.

Over the coming weeks, KABN will begin its rollout of products and programs, initially on an invitation-only basis to its customers, social media, gaming and its network partners.

About DLI – www.disruptedlogic.com

Founded in 2012 in Vancouver, BC, by a team of industry professionals from gaming, advertising, technology and the motion picture industry, Disrupted Logic Interactive currently has 7 employees. Disrupted Logic has developed the ctalyst® technology which is live and in market.

ctalyst® is a one-stop, self-contained, and full-service platform similar in concept to Google’s AdWords, AdSense, and Analytics, but designed just for video games and e-sports. ctalyst® ads are a natural, native, and genuine playable and enjoyable part of the video gaming experience. The ctalyst® engine manages over 150 user datapoints and analytics on an opt-in basis.

The platform has 130 participating game producers and an additional 150 developers awaiting invitations with an audience peak reach of approximately 60 to 70 million people. Disrupted Logic expects that when the additional 150 game developers are invited into the program, the platform’s reach to the gaming industry could extend to over 500 million users worldwide.

For more information, please visit: www.disruptedlogic.com

About KABN – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.

KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs.

KABN Systems NA Holdings Corp. is publicly traded on the Canadian Securities Exchange under the symbol: KABN

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

Ben Kessler
Chief Executive Officer
647-725-7742 Ext. 700

[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Tags: , , , , , ,
Posted in Featured, KABN Systems NA Holdings Corp. | Comments Off on $KABN.ca – Liquid Avatar Integrates with Disrupted Logic Interactive to Reach 60 Million+ Gamers

Datametrex $DM.ca Obtains Rights to Sell COVID-19 Home Test Kits With FDA Registration

Posted by AGORACOM-JC at 8:11 AM on Tuesday, June 16th, 2020

– Secured non-exclusive rights to sell RapiGEN Inc. (“RapiGEN”) COVID-19 home test kitsi.

– These test kits are FDA registered, suitable for point of care testing, no extra equipment is needed, and are easy to use with results in 5-10 minutes.

TORONTO, June 16, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell RapiGEN Inc. (“RapiGEN”) COVID-19 home test kitsi. These test kits are FDA registered, suitable for point of care testing, no extra equipment is needed, and are easy to use with results in 5-10 minutes.

If the specimen contains IgM antibodies to SARS-CoV-2, a colored line appears in the T line area. The RapiGen home test kit is a lateral flow immunochromatographic assay (LFIA) for the qualitative detection of IgG antibodies to COVID19 in blood, serum or plasma specimens.

Watch the sample video of the test here: https://datametrex.com/investor/video.html

The Company’s primary goal is to sell to the current clients for their operations out of Canada, and the Company intends to apply for Health Canada approval with an Interim Order (“IO”).

“These test kits are revolutionary in expediting the process of testing since it cuts out the processing time by a fraction, aiding in an earlier detection of the virus, a more accurate prediction of the positive cases and a decrease of the infection rate,” said Marshall, CEO of the Company.

“Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA registration under EUA allowing us to help our neighbours to the south and any Canadian company with operations in the US and Europe,” says Andrew Ryu, Chairman of the Company.

The Company’s ability to fulfill any purchase order for Covid-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

The Company is exploring oportunities with Michigan Economic Development Corporation and Governor’s Office of Business and Economic Development in California looking into retail, film, healthcare oportunities. With months into the spread of the COVID-19 in Califoria, widespread diagnostic testing still isn’t available. Testing voids, stemming from an overwhelmed supply chain and a disjointed public health system, have hit hardest in California’s rural north. The Michigan Department of Health and Human Services, Michigan State Police, and local health departments are looking to expand COVID-19 testing directly to the community. Michegan now is easing coronavirus restrictions with six-part reopening plan that includes testing to ensure the state lowers the chance of a second wave and to further protect Michigan families.

About RapiGEN Inc.
RapiGEN has the manufacturing technology of Gold colloid which is the core material of immunochromatographic assay. RapiGen has developed a convenient, quick and accurate diagnostic kit, focused on developing distinctive next-generation diagnostic kits from existing products. Currently researching and developing various diagnostic kits for increasingly epidemic pathogenesis such as Covid-19, Shigella, Cholera and Entrohemorrhagic E.coli. Additional information on RapiGEN is available at http://rapigen-inc.com/

About Food and Drug Aministration EUA
On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.

About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

i Source: FDA [RAPIGEN INC] – BIOCREDIT COVID-19 IgG+IgM Duo -https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=680769&lpcd=QKO    

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5d8342b8-7212-4584-8839-edd666c79914

RapiGEN COVID-19 Home Test
RapiGEN COVID-19 home test kit procedure instructions.

Tags: , , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Obtains Rights to Sell COVID-19 Home Test Kits With FDA Registration

« Older Entries
Newer Entries »